Correlation Between JB Chemicals and Privi Speciality

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JB Chemicals and Privi Speciality at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JB Chemicals and Privi Speciality into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JB Chemicals Pharmaceuticals and Privi Speciality Chemicals, you can compare the effects of market volatilities on JB Chemicals and Privi Speciality and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JB Chemicals with a short position of Privi Speciality. Check out your portfolio center. Please also check ongoing floating volatility patterns of JB Chemicals and Privi Speciality.

Diversification Opportunities for JB Chemicals and Privi Speciality

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between JBCHEPHARM and Privi is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding JB Chemicals Pharmaceuticals and Privi Speciality Chemicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Privi Speciality Che and JB Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JB Chemicals Pharmaceuticals are associated (or correlated) with Privi Speciality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Privi Speciality Che has no effect on the direction of JB Chemicals i.e., JB Chemicals and Privi Speciality go up and down completely randomly.

Pair Corralation between JB Chemicals and Privi Speciality

Assuming the 90 days trading horizon JB Chemicals Pharmaceuticals is expected to under-perform the Privi Speciality. But the stock apears to be less risky and, when comparing its historical volatility, JB Chemicals Pharmaceuticals is 1.15 times less risky than Privi Speciality. The stock trades about -0.09 of its potential returns per unit of risk. The Privi Speciality Chemicals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  171,260  in Privi Speciality Chemicals on December 28, 2024 and sell it today you would lose (8,490) from holding Privi Speciality Chemicals or give up 4.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

JB Chemicals Pharmaceuticals  vs.  Privi Speciality Chemicals

 Performance 
       Timeline  
JB Chemicals Pharmac 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days JB Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Privi Speciality Che 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Privi Speciality Chemicals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Privi Speciality is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

JB Chemicals and Privi Speciality Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JB Chemicals and Privi Speciality

The main advantage of trading using opposite JB Chemicals and Privi Speciality positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JB Chemicals position performs unexpectedly, Privi Speciality can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Privi Speciality will offset losses from the drop in Privi Speciality's long position.
The idea behind JB Chemicals Pharmaceuticals and Privi Speciality Chemicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals